Teal Health

What Teal Health does

Teal Health is a San Francisco-based women's health technology company that has developed the Teal Wand, the first and only FDA-authorized at-home self-collection device for cervical cancer screening, authorized by the FDA on May 9, 2025 and made available nationwide across all 50 U.S. states in January 2026. The product targets U.S. women aged 25–65 with a cervix who are due or overdue for cervical cancer screening, including populations historically underserved by in-clinic speculum exams such as LGBQ+ individuals, higher-BMI women, and Black, Hispanic, Native American, and Asian women. The clinical evidence base rests on the SELF-CERV trial — a 609-participant, 16-site nationwide study published in JAMA Network Open — which demonstrated 96% sensitivity for detecting CIN2+ cervical precancer and 94% patient preference over in-clinic screening.

The core offering combines the Teal Wand self-collection device with an end-to-end telehealth platform (app.tealhealth.co) under which patients complete online eligibility screening, attend a required brief virtual visit with a clinician from the affiliated medical group Teal Medical, P.A., receive a pre-validated kit via USPS, self-collect a vaginal sample, mail it to a partner lab for processing with the FDA-approved Roche cobas HPV Primary HPV assay, and view results in a secure patient portal. The device is pre-labeled and pre-validated by Teal providers, requires no in-home activation, and uses a sample-stability-validated USPS mailer.

Teal Health generates revenue primarily through direct-to-consumer kit sales ($99 with insurance, $249 cash-pay) plus professional services fees from telehealth consultations, distributed via its own e-commerce storefront, the Thatch Marketplace employer-benefits channel, and in-network coverage with major U.S. health insurers including Cigna, Aetna, Anthem Blue Cross, Blue Cross Blue Shield, and United Healthcare. The company has raised approximately $20.48 million across disclosed funding, holds FDA authorization and patents on the Teal Wand, and has earned TIME Best Inventions 2025 and Fast Company design innovation recognition.

Name

Teal Health

Legal name

Teal Health, Inc.

Website

https://getteal.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Teal Health is a San Francisco-based women's health company that developed the Teal Wand, the first FDA-authorized at-home self-collection device for cervical cancer screening, serving U.S. women aged 25–65 via a telehealth platform, major insurance plans, and employer benefits channels.

Ownership category

akta.pro rank

Product category

Cervical Cancer Screening

NAICS

Medical and Diagnostic Laboratories (62151), Home Health Care Services (621610)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)

Keywords

• Cervical cancer screening
• At-home HPV testing
• Telehealth screening
• Self-collection device
• Women's preventive care

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Marketing or Sales, Operations, Personnel, Supply Chain, Infrastructure

Revenue model

1. Direct-to-consumer Teal Wand kit sales: Hardware/device + consumable self-collection kit sold direct to consumer via getteal.com and the Teal portal at $99 with most major insurance plans or $249 cash pay (reduced from $499). Includes access to a Teal medical provider, prescription, USPS fulfillment, and Primary HPV lab processing. HSA/FSA eligible. One-time transaction per screening cycle.
2. Telehealth consultation fees: Revenue from required virtual Intro Visits and any follow-up video visits with Teal medical providers (Teal Medical, P.A.); covered by most major insurance plans and HSA/FSA. Billed as professional services alongside the kit.
3. Employer/benefits channel (Thatch Marketplace): B2B/employer distribution of at-home cervical cancer screening as an employee benefit, accessed via tax-free healthcare dollars through Thatch Marketplace — enabling screening to be embedded in employer benefit packages.
4. Clinical research collaborations and pilot programs: Revenue/grant-funded pilot and clinical research programs (e.g., WashU Medicine underserved-community pilot, NIH/NCI SBIR grant for clinical validation) supporting device validation, evidence generation, and access expansion.

Pricing tiers

Go-to-market motion5 records

Distribution channels5 records

Marketing channels9 records

Core offering

Teal Health sells an FDA-authorized at-home cervical cancer screening kit (Teal Wand) paired with a telehealth prescribing and results service. Eligible women complete an online eligibility questionnaire, complete a ~10-minute virtual Intro Visit with a Teal provider, receive the kit via USPS, self-collect a vaginal sample at home, mail it to a partner lab for Roche cobas Primary HPV testing, and access results and follow-up navigation through the Teal Portal. The bundle is priced at $99 in-network with insurance or $249 cash pay, with HSA/FSA eligibility.

Product overview

Teal Health offers a single integrated at-home cervical cancer screening service rather than a modular product suite. The Teal Wand is the FDA-authorized at-home self-collection device at the heart of the offering; it is paired with the Teal Health Telehealth Platform, which routes patients to clinicians from Teal Medical, P.A. for the screening visit, and the Teal Portal, where patients complete intake and view their lab results. The clinical evidence behind the service is captured in the SELF-CERV Clinical Study, and the company's annual "State of Her Health" research report supports its women's health mission.

Differentiator

Problem solved

Functional benefit

Brands

• Teal Wand: Teal Health's FDA-authorized at-home self-collection device for cervical cancer screening, used with the cobas HPV test from Roche.

Products and services

• Teal Wand at-home cervical cancer screening kit An FDA-authorized at-home self-collection device bundled with a virtual Intro Visit with a Teal provider, a prescription, USPS fulfillment, primary HPV testing at a partner lab, and results delivered through the Teal Portal. Marketed to women 25–65 at average risk for cervical cancer.
• Teal Health telehealth cervical cancer screening service Professional telehealth service providing online eligibility screening, ~10-minute virtual Intro Visits with licensed providers, prescription routing, results delivery through the Teal Portal, and navigation to in-person follow-up care (including on-site support for higher-BMI patients) when needed.

Quantifiable outcome

• 96% sensitivity for detecting cervical precancer (CIN2+) — equal to clinician-collected samples
• +7 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Partnerships

16 partnerships are on record, tiered flagship and core.

• Washington University School of Medicine (WashU Medicine)flagshipStrategic or Co-development Partner · 28 May 2026Teal Health and WashU Medicine in St. Louis launched a pilot study in Illinois and Missouri using at-home HPV self-collection kits at community events to increase cervical cancer screening participation among underserved women and evaluate different enrollment pathways for scaling community-based screening.
• Midi HealthcoreGTM or Marketing Partner · 7 January 2026Participated in Teal Health's unified Cervical Cancer Awareness Month campaign alongside 30+ women's health companies. The joint campaign promotes FDA-authorized self-collection testing as a more convenient alternative to traditional speculum exams.
• Maven CliniccoreGTM or Marketing Partner · 7 January 2026Participated in Teal Health's unified Cervical Cancer Awareness Month campaign promoting at-home HPV self-collection and cervical cancer screening during January 2026.
• WispcoreGTM or Marketing Partner · 7 January 2026Participated in Teal Health's unified Cervical Cancer Awareness Month campaign promoting FDA-authorized self-collection testing as a more convenient alternative to traditional speculum exams.
• KindbodycoreGTM or Marketing Partner · 7 January 2026Participated in Teal Health's unified Cervical Cancer Awareness Month campaign promoting FDA-authorized at-home self-collection testing across the women's health ecosystem.
• EvvycoreGTM or Marketing Partner · 7 January 2026Participated in Teal Health's unified Cervical Cancer Awareness Month PSA campaign targeting women overdue for cervical cancer screening with messaging on self-collection HPV testing.
• The Flex CompanycoreGTM or Marketing Partner · 7 January 2026Participated in Teal Health's unified Cervical Cancer Awareness Month campaign alongside Midi Health, Maven Clinic, Wisp, Kindbody, Evvy, and others to promote cervical cancer screening via self-collection HPV testing.
• Thatch MarketplacecoreChannel Partner/ Reseller/ Distributor · 16 December 2025Teal Health partnered with Thatch Marketplace to distribute at-home cervical cancer screening via employer-sponsored tax-free healthcare benefits. Employees can access the FDA-authorized Teal Wand through Thatch's personalized benefits platform, extending Teal's reach into employer benefit packages.
• RocheflagshipTechnology or IntegrationTeal Health's Teal Wand self-collected sample is tested using the FDA-approved Roche cobas HPV Primary HPV assay — the same test recommended by the American Cancer Society and USPSTF and used in clinician-collected samples. The cobas HPV test is core to the clinical validation of the Teal Wand.
• CignaflagshipChannel Partner/ Reseller/ DistributorMajor U.S. health insurer covering Teal Wand at-home cervical cancer screening; in-network pricing available at $99 with insurance. Teal Health is working with major insurance plans to expand coverage.
• AetnaflagshipChannel Partner/ Reseller/ DistributorMajor U.S. health insurer covering Teal Wand at-home cervical cancer screening as in-network preventive care.
• Anthem Blue CrossflagshipChannel Partner/ Reseller/ DistributorMajor U.S. health insurer covering Teal Wand at-home cervical cancer screening; in-network pricing at $99 with insurance.
• Blue Cross Blue ShieldflagshipChannel Partner/ Reseller/ DistributorMajor U.S. health insurer covering Teal Wand at-home cervical cancer screening; in-network pricing at $99 with insurance.
• United HealthcareflagshipChannel Partner/ Reseller/ DistributorMajor U.S. health insurer covering Teal Wand at-home cervical cancer screening; in-network pricing at $99 with insurance.
• StripecoreTechnology or IntegrationThird-party payment processor integrated into the Teal Health Platform for processing kit and service payments; Teal Health does not retain payment-card information, relying on Stripe for PCI-handled payment processing.
• Teal Medical, P.A.flagshipImplementation/ SI/ Consulting PartnerIndependent physician-owned medical group with which Teal Health contracts to provide online telehealth clinical consultations, prescriptions, and treatment. Teal licenses the 'Teal Health' brand name to this Medical Group, which delivers all clinical services via the Teal Platform.

Scale indicators13 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Everlywell: Direct-to-consumer at-home diagnostics company offering self-collected lab tests with telehealth oversight and a similar D2C + insurance/HSA model, making it the closest analog to Teal's at-home self-collection funnel.
• LetsGetChecked: At-home diagnostics platform with self-collected sample kits, telehealth consultation, and partner lab processing, mirroring Teal's end-to-end kit-to-results workflow for at-home health screening.

Broad incumbents

• Hologic: Incumbent in cervical cancer screening with the ThinPrep Pap and Aptima HPV assays, the dominant supplier to U.S. OB/GYNs, and the most likely large incumbent to launch a competing at-home self-collection kit.
• Becton Dickinson: Manufacturer of the BD Onclarity HPV assay and a major women's health diagnostics player, with the scale, payer relationships, and clinical channel to compete with Teal if it enters at-home self-collection.
• Qiagen: Long-established HPV testing company behind the digene HC2 assay and a pipeline of self-collection sample technologies, with deep clinical lab reach that could translate into a competing at-home offering.
• Roche Diagnostics: Provider of the cobas HPV Primary assay that Teal depends on, and a global diagnostics leader with the assay IP, lab infrastructure, and capital to vertically integrate into at-home self-collection screening.
• Hims & Hers Health: Public D2C telehealth platform with a nationwide provider network, e-commerce storefront, and a growing women's health category, representing a broad incumbent that could expand into at-home cervical screening.

Others

• Labcorp: Major U.S. clinical lab network and a Teal Health investor; operates HPV testing services and physician channels that make it both a distribution partner and a potential competitive threat if it bundles at-home self-collection.

Emerging players

• Midi Health: Virtual menopause and women's midlife health clinic and an active Teal co-marketing partner, overlapping on the same 25-65 women's health customer base and care-navigation entry point.
• Maven Clinic: Digital women's and family health platform serving employers and health plans; co-markets with Teal during Cervical Cancer Awareness Month and addresses the same screening, fertility, and preventive care buyer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/tealhealth
• YouTubeyoutube.com/@tealhealth
• Facebookfacebook.com/profile.php?id=100089478520281
• LinkedInlinkedin.com/company/teal-healthco
• Instagraminstagram.com/teal.health

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds6 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teal Health